Impact of COVID 19 on Psoriasis Patients

COVID 19 Impact on Psoriasis Patients, a Hospital Based Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05381402

Enrollment

230

Registered

2022-05-19

Start date

2022-05-20

Completion date

2022-06-10

Last updated

2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Impact of COVID19 on Psoriasis Patients

Brief summary

The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis patients. This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian psoriasis patients.

Interventions

OTHERQuestionnaire

Questionnaire to assess the impact of COVID 19 on psoriasis patients

Study design

Observational model

CASE_CROSSOVER

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Psoriaisis patients

Exclusion criteria

* Children

Design outcomes

Primary

Measure	Time frame	Description
Questionnaire	2-4 weeks	To assess the effect of COVID 19 on psoriasis disease, treatment, follow up, vaccine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026